Maternal supplementation with Limosilactobacillus reuteri FN041 for preventing infants with atopic dermatitis: study protocol for a randomized controlled trial

BACKGROUND: Atopic dermatitis (AD) has increased rapidly with rapid urbanization; however, the treatment options for AD are lacking because the commonly used therapies can only alleviate symptoms. Limosilactobacillus reuteri (L. reuteri), FN041 is a specific strain isolated from human breast milk, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Renqiang, Ma, Yizhe, Luo, Zichen, Qi, Ce, Xie, Anni, Jiang, Yifan, Zhu, Baoli, Sun, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588667/
https://www.ncbi.nlm.nih.gov/pubmed/37869669
http://dx.doi.org/10.3389/fmicb.2023.1267448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588667/
https://www.ncbi.nlm.nih.gov/pubmed/37869669
http://dx.doi.org/10.3389/fmicb.2023.1267448

Ejemplares similares